We are live on ! Find out more
IPXL

Impax Laboratories, Inc.
IPXL

Delisted

IPXL was delisted on the 4th of May, 2018.

Back to rankings

149 hedge funds and large institutions have $1.12B invested in Impax Laboratories, Inc. in 2013 Q2 according to their latest regulatory filings, with 149 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

81.35% more ownership

Funds ownership: 0% → 81.35% (+81%)

47% less call options, than puts

Call options by funds: $3.82M | Put options by funds: $7.28M

Holders
149
Holders Change
+149
Holders Change %
–
% of All Funds
4.85%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.1%
New
149
Increased
–
Reduced
–
Closed
–
Calls
$3.82M
Puts
$7.28M
Net Calls
-$3.46M
Net Calls Change
-$3.46M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

IPXL Hedge Fund Activity: Q2 2013 in Review

149 of the 3,075 institutional investors tracked by Wall St. Rank reported a position in Impax Laboratories, Inc. (IPXL) for Q2 2013, worth a combined $1.12B.

Buyers outnumbered sellers: 149 funds opened new IPXL positions and 0 closed out — a net gain of 149 holders — while 0 added to existing stakes and 0 trimmed.

  • 149 institutional investors held Impax Laboratories, Inc. (IPXL) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $1.12B of Impax Laboratories, Inc. stock for Q2 2013.
  • 149 funds opened new Impax Laboratories, Inc. positions in Q2 2013 and 0 closed out, a net change of +149 holders.

Based on aggregated 13F filings for Q2 2013.